- Home
- ULS vs ASND Comparison
ULS vs ASND Comparison
Compare ULS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULS
- ASND
- Stock Information
- Founded
- ULS 1894
- ASND 2006
- Country
- ULS United States
- ASND Denmark
- Employees
- ULS N/A
- ASND N/A
- Industry
- ULS
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ULS
- ASND Health Care
- Exchange
- ULS Nasdaq
- ASND Nasdaq
- Market Cap
- ULS 9.8B
- ASND 8.4B
- IPO Year
- ULS 2024
- ASND 2015
- Fundamental
- Price
- ULS $51.93
- ASND $128.13
- Analyst Decision
- ULS Buy
- ASND Strong Buy
- Analyst Count
- ULS 11
- ASND 14
- Target Price
- ULS $49.00
- ASND $192.07
- AVG Volume (30 Days)
- ULS 702.9K
- ASND 360.8K
- Earning Date
- ULS 01-24-2025
- ASND 02-05-2025
- Dividend Yield
- ULS 0.72%
- ASND N/A
- EPS Growth
- ULS 8.21
- ASND N/A
- EPS
- ULS 1.51
- ASND N/A
- Revenue
- ULS $2,815,000,000.00
- ASND $365,187,374.00
- Revenue This Year
- ULS $7.80
- ASND $9.76
- Revenue Next Year
- ULS $5.99
- ASND $81.02
- P/E Ratio
- ULS $34.28
- ASND N/A
- Revenue Growth
- ULS 7.32
- ASND 115.54
- 52 Week Low
- ULS $33.15
- ASND $111.09
- 52 Week High
- ULS $59.23
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- ULS N/A
- ASND 41.36
- Support Level
- ULS N/A
- ASND $126.38
- Resistance Level
- ULS N/A
- ASND $137.54
- Average True Range (ATR)
- ULS 0.00
- ASND 5.53
- MACD
- ULS 0.00
- ASND -1.14
- Stochastic Oscillator
- ULS 0.00
- ASND 11.21
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.